Amazon.com, Inc. (AMZN)
NASDAQ: AMZN · Real-Time Price · USD
214.75
-19.36 (-8.27%)
At close: Aug 1, 2025, 4:00 PM
215.03
+0.28 (0.13%)
After-hours: Aug 1, 2025, 7:59 PM EDT
Longboard Pharmaceuticals Stock Forecast
Stock Price Forecast
The 45 analysts that cover Longboard Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $261.18, which forecasts a 21.62% increase in the stock price over the next year. The lowest target is $195 and the highest is $305.
Price Target: $261.18 (+21.62%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Longboard Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 24 | 24 | 23 | 23 | 23 | 23 |
Buy | 19 | 20 | 20 | 20 | 21 | 21 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 44 | 45 | 44 | 44 | 45 | 45 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
DA Davidson | DA Davidson | Strong Buy Maintains $230 → $265 | Strong Buy | Maintains | $230 → $265 | +23.40% | Aug 1, 2025 |
Citigroup | Citigroup | Strong Buy Maintains $265 → $270 | Strong Buy | Maintains | $265 → $270 | +25.73% | Aug 1, 2025 |
Oppenheimer | Oppenheimer | Buy Maintains $250 → $245 | Buy | Maintains | $250 → $245 | +14.09% | Aug 1, 2025 |
BMO Capital | BMO Capital | Buy Maintains $270 → $280 | Buy | Maintains | $270 → $280 | +30.38% | Aug 1, 2025 |
JP Morgan | JP Morgan | Buy Maintains $255 → $265 | Buy | Maintains | $255 → $265 | +23.40% | Aug 1, 2025 |
Financial Forecast
Revenue This Year
709.67B
from 637.96B
Increased by 11.24%
Revenue Next Year
778.49B
from 709.67B
Increased by 9.70%
EPS This Year
6.32
from 5.53
Increased by 14.31%
EPS Next Year
7.42
from 6.32
Increased by 17.39%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 741.6B | 816.9B | 905.7B | ||
Avg | 709.7B | 778.5B | 856.1B | ||
Low | 666.3B | 705.5B | 787.2B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 16.2% | 15.1% | 16.3% | ||
Avg | 11.2% | 9.7% | 10.0% | ||
Low | 4.4% | -0.6% | 1.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 7.17 | 8.93 | 10.78 | ||
Avg | 6.32 | 7.42 | 9.10 | ||
Low | 5.19 | 5.86 | 7.41 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 29.7% | 41.2% | 45.3% | ||
Avg | 14.3% | 17.4% | 22.7% | ||
Low | -6.1% | -7.3% | -0.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.